Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Chemotherapy + Bevacizumab +/- Immunotherapy for Advanced Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial is for never or light smokers with non-squamous non-small cell lung cancer that has spread and progressed after other treatments. It tests the addition of bevacizumab to carboplatin and paclitaxel to see if it improves survival.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.